Pharmacology for therapeutic planning. Antidiabetic. Oral agent.
|
Accession number;01A0265234
|
| Title;Pharmacology for therapeutic planning. Antidiabetic. Oral agent. |
| Author;
KONO HARUICHI
(National Sanatorium Kanagawa Hospital)
|
Journal Title;Clinics & Drug Therapy
|
Journal Code:S0115B
|
ISSN:0913-7505
|
|
VOL.20;NO.2;PAGE.173-179(2001)
|
| Figure&Table&Reference;FIG.2, TBL.3, REF.17 |
| Pub. Country;Japan |
| Language;Japanese |
| Abstract;Etiology and the disease type of diabetes mellitus, and the oral drug for treatment of diabetes mellitus are outlined. Molecular genetics (molecular geneticity of type 2 diabetes mellitus, candidate gene approach, random marker approach) and insulin resistance of type 2 diabetes mellitus are explained. In addition, action mechanisms of the antidiabetics (sulfonylurea medicine, sulfonamide medicine, biguanide medicine, .ALPHA.-glucosidase inhibitor, insulin resistance improving drug, fast-acting insulin secretion facilitator) are shown. Finally, serious side effect cases of the oral antidiabetics (acarbose, etc.) are mentioned. |
|
|
|
Related Articles;
|
|
